Back

Morphological and clinical implications of the optical coherence tomography-derived lipid core burden index.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Lesion characteristics in coronary artery disease Angiography, Invasive Imaging ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Flavio Giuseppe Biccire

Inselspital - University of Bern, Bern (Switzerland)

5 More presentations in this session

Presentation thumbnail
Misclassification rate of the angiographically identified culprit lesion in NSTEMI
Doctor K. Ekstroem (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Differences in microRNA expression in pericoronary tissue adjacent to atherosclerotic plaque and from lesion-free coronary artery
Doctor M. Marketou (Heraklion, GR)
Abstract Slides Video
Presentation thumbnail
Association of serum MMP9 with adverse features of plaque progression in patients with chronic coronary syndrome (CCS).
Doctor C. Caselli (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Identification of coronary plaque rupture or erosion by preprocedural computed tomography angiography in patients with non-st-segment elevation acute coronary syndrome
Doctor T. Nagamine (Ibaraki, JP)
Abstract Slides Video
Presentation thumbnail
Heterogeneous plaque geometry is associated with major adverse cardiovascular events
Doctor Z. Gu (Cambridge, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Lesion characteristics in coronary artery disease

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Plaque-based management in coronary artery disease: what drives coronary artery disease risk?
thumbnail
Congress Presentation
Long-term prognostic value of residual lipid burden in acute myocardial infarction: a three-vessel optical coherence tomography study
thumbnail
Congress Presentation
Lipid core burden index and new LDL-C calculation in predicting non-culprit coronary events in very high-risk patients: Insights from the Lipid-Rich Plaque Study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources